A detailed history of Macquarie Group LTD transactions in Smith & Nephew PLC stock. As of the latest transaction made, Macquarie Group LTD holds 217 shares of SNN stock, worth $6,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
217
Previous 217 -0.0%
Holding current value
$6,753
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$24.33 - $31.28 $267 - $344
-11 Reduced 4.82%
217 $5,000
Q1 2022

May 16, 2022

SELL
$30.84 - $36.38 $616 - $727
-20 Reduced 8.06%
228 $7,000
Q4 2021

Feb 11, 2022

BUY
$31.98 - $37.15 $671 - $780
21 Added 9.25%
248 $9,000
Q3 2021

Nov 12, 2021

BUY
$34.34 - $44.17 $3,056 - $3,931
89 Added 64.49%
227 $8,000
Q2 2021

Aug 13, 2021

BUY
$37.86 - $44.01 $1,249 - $1,452
33 Added 31.43%
138 $6,000
Q1 2021

May 14, 2021

BUY
$36.75 - $45.88 $3,858 - $4,817
105 New
105 $4,000

Others Institutions Holding SNN

About SMITH & NEPHEW PLC


  • Ticker SNN
  • Exchange OTC
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 435,348,000
  • Market Cap $13.5B
  • Description
  • Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...
More about SNN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.